These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 14510982)
41. The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Gerritsen MJ; Boezeman JB; van Vlijmen-Willems IM; Van de Kerkhof PC Br J Dermatol; 1994 Jul; 131(1):57-63. PubMed ID: 7519032 [TBL] [Abstract][Full Text] [Related]
42. Quantification of epidermal cell populations in the centre and margin of stable psoriatic plaques. Mommers JM; van Rossum MM; van Hooijdonk CA; van Erp PE; van de Kerkhof PC Arch Dermatol Res; 1999; 291(2-3):88-92. PubMed ID: 10195395 [TBL] [Abstract][Full Text] [Related]
43. Reduction of epidermal abnormalities and inflammatory changes in psoriatic plaques during treatment with vitamin D3 analogs. van de Kerkhof PC J Investig Dermatol Symp Proc; 1996 Apr; 1(1):78-81. PubMed ID: 9627698 [TBL] [Abstract][Full Text] [Related]
44. Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric study. van Rossum MM; van Erp PE; van de Kerkhof PC Dermatology; 2001; 203(2):148-52. PubMed ID: 11586014 [TBL] [Abstract][Full Text] [Related]
45. Response of psoriasis to a new topical retinoid, AGN 190168. Esgleyes-Ribot T; Chandraratna RA; Lew-Kaya DA; Sefton J; Duvic M J Am Acad Dermatol; 1994 Apr; 30(4):581-90. PubMed ID: 7512583 [TBL] [Abstract][Full Text] [Related]
46. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions. Kokolakis G; Giannikaki E; Stathopoulos E; Avramidis G; Tosca AD; Krüger-Krasagakis S Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184 [TBL] [Abstract][Full Text] [Related]
47. Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma. Duvic M; Martin AG; Kim Y; Olsen E; Wood GS; Crowley CA; Yocum RC; Arch Dermatol; 2001 May; 137(5):581-93. PubMed ID: 11346336 [TBL] [Abstract][Full Text] [Related]
48. Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes. Gottlieb S; Hayes E; Gilleaudeau P; Cardinale I; Gottlieb AB; Krueger JG J Cutan Pathol; 1996 Oct; 23(5):404-18. PubMed ID: 8915849 [TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factor driving aberrant keratin expression pattern contributes to the pathogenesis of psoriasis. Jiang M; Li B; Zhang J; Hu L; Dang E; Wang G Exp Cell Res; 2017 Nov; 360(2):310-319. PubMed ID: 28928080 [TBL] [Abstract][Full Text] [Related]
50. Tape stripping induces marked epidermal proliferation and altered TGF-alpha expression in non-lesional psoriatic skin. Hatta N; Takata M; Kawara S; Hirone T; Takehara K J Dermatol Sci; 1997 Feb; 14(2):154-61. PubMed ID: 9039979 [TBL] [Abstract][Full Text] [Related]
51. Proliferation, differentiation, and inflammation in normal and hyperproliferative skin using multiparameter flow cytometry. van Erp PE Methods Mol Biol; 2005; 289():239-50. PubMed ID: 15502189 [TBL] [Abstract][Full Text] [Related]
52. Mutational analysis of epidermal and hyperproliferative type I keratins in mild and moderate psoriasis vulgaris patients: a possible role in the pathogenesis of psoriasis along with disease severity. Elango T; Sun J; Zhu C; Zhou F; Zhang Y; Sun L; Yang S; Zhang X Hum Genomics; 2018 May; 12(1):27. PubMed ID: 29784039 [TBL] [Abstract][Full Text] [Related]
53. The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis. Lin YK; Wong WR; Chang YC; Chang CJ; Tsay PK; Chang SC; Pang JH Dermatology; 2007; 214(2):155-61. PubMed ID: 17341866 [TBL] [Abstract][Full Text] [Related]
54. Notch signaling may be involved in the abnormal differentiation of epidermal keratinocytes in psoriasis. Ota T; Takekoshi S; Takagi T; Kitatani K; Toriumi K; Kojima T; Kato M; Ikoma N; Mabuchi T; Ozawa A Acta Histochem Cytochem; 2014 Aug; 47(4):175-83. PubMed ID: 25392571 [TBL] [Abstract][Full Text] [Related]
55. Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study. Kleinpenning MM; Smits T; Ewalds E; van Erp PE; van de Kerkhof PC; Gerritsen MJ Br J Dermatol; 2006 Sep; 155(3):539-45. PubMed ID: 16911278 [TBL] [Abstract][Full Text] [Related]
56. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience. Lecha M; Mirada A; López S; Artés M; J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284 [TBL] [Abstract][Full Text] [Related]
57. Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream. van der Vleuten CJ; de Jong EM; van de Kerkhof PC Clin Exp Dermatol; 1996 Nov; 21(6):409-14. PubMed ID: 9167334 [TBL] [Abstract][Full Text] [Related]
58. Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis. Lago E; Carneiro S; Cuzzi T; Magalhães G; Cássia F; Pessanha F; Ramos-e-Silva M J Cutan Pathol; 2007 Jan; 34(1):15-21. PubMed ID: 17214849 [TBL] [Abstract][Full Text] [Related]
59. Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas. Hamada T; Sugaya M; Tokura Y; Ohtsuka M; Tsuboi R; Nagatani T; Tani M; Setoyama M; Matsushita S; Kawai K; Yonekura K; Yoshida T; Saida T; Iwatsuki K J Dermatol; 2017 Feb; 44(2):135-142. PubMed ID: 27543197 [TBL] [Abstract][Full Text] [Related]
60. Nestin expression is increased in the suprabasal epidermal layer in psoriasis vulgaris. Watarai A; Amoh Y; Maejima H; Hamada Y; Katsuoka K Acta Derm Venereol; 2013 Jan; 93(1):39-43. PubMed ID: 22854836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]